Therapeutic Advances in Neurological Disorders-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-11-05 ms3655465666

听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！

156 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-12-28 乌云背后的幸福线来自上海

投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收

79 0

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-01-03 ms66265655 来自上海

审稿速度:2.0 | 投稿命中率:95.0
经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。

62 0

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2024-01-02 ms158866131 来自上海

审稿速度:3.0 | 投稿命中率:75.0
经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下

103 0

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-12-28 ms40000757937429564 来自上海

这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。

109 0

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-10-05 ShinyLiu 来自四川省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：神经病学
经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。

84 0

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-04-07 huolongguo2222 来自重庆

我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-05-16 ms2000001410392408

审稿速度:3.0 | 投稿命中率:75.0
经验分享：****预测2022年多少？

158 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

俢回包括几个方面？

115 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067385, encodeId=2c6c106e3855a, content=听说这个期刊发文量不大，一开始投稿有点忐忑，5月份投稿，刚刚收到邮件proof让缴费。看来还是要对自己有点信心啊！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3655465666, createdTime=Fri Nov 05 20:02:16 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177832, encodeId=437921e783236, content=投稿发表时间：普遍一审一个月，二审一个月，总历时2-3个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Thu Dec 28 17:11:11 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2179054, encodeId=1d7021e905442, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：投了一篇，一审查不多一个月左右，给了一些反馈和建议，二审也等了1个月左右，总的来说还是比较顺利的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Wed Jan 03 15:55:20 CST 2024, time=2024-01-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2178723, encodeId=05fc21e8723be, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：听师姐说这本期刊还是比较受同行认可的，查了下中科院医学2区的高质量期刊，自引率一直都很低3.7%，特来关注一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91306407063, createdName=ms158866131, createdTime=Tue Jan 02 09:41:54 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177809, encodeId=1e8f21e78099e, content=这本期刊在神经科学领域具有很高的影响力，能够被收录在JCR Q1区的期刊我觉得也是实至名归。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=ms40000757937429564, createdTime=Thu Dec 28 16:20:23 CST 2023, time=2023-12-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2161085, encodeId=05312161085c5, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：神经病学 经验分享：对国人比较友好。期刊编委专业性挺高。四个审稿人先后审稿2轮接受，审稿意见比较专业。期刊处理速度中等，从投稿到接受花了小半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231005/a3f79baa39aa492d8d2bc406a1fb6263/70715e75fe4a4d1f995e08a90e40322d.jpg, createdBy=50f05323474, createdName=ShinyLiu, createdTime=Thu Oct 05 21:50:02 CST 2023, time=2023-10-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2124265, encodeId=9077212426580, content=我的天呀，一个多月了，还没有送外审，完全没有动静，催了也没有任何反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/17/634d0059013df8b90d5c08fdd56aad9d.jpg, createdBy=3cb51622124, createdName=huolongguo2222, createdTime=Fri Apr 07 11:58:51 CST 2023, time=2023-04-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1220160, encodeId=87c5122016098, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：****预测2022年多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db6b5402078, createdName=ms2000001410392408, createdTime=Mon May 16 23:30:34 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105612, encodeId=8e931105612e4, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105611, encodeId=355c110561114, content=什么叫俢回？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 桑晒麦拉

什么叫俢回？

92 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务